share_log

Seagen and Zai Lab Announce Regional Strategic Collaboration And License Agreement For TIVDAK; Seagen Will Receive An Upfront Payment Of $30M, As Well As Development, Regulatory, And Commercial Milestone Payments, And Tiered Royalties On Sales Of TIVDAK

Seagen and Zai Lab Announce Regional Strategic Collaboration And License Agreement For TIVDAK; Seagen Will Receive An Upfront Payment Of $30M, As Well As Development, Regulatory, And Commercial Milestone Payments, And Tiered Royalties On Sales Of TIVDAK

SeaGen和再鼎医药-SB宣布达成TIVDAK的区域战略合作和许可协议;Seagen将获得3000万美元的预付款,以及开发、监管和商业里程碑付款,以及销售TIVDAK的分级特许权使用费
Benzinga Real-time News ·  2022/09/27 08:06

Seagen and Zai Lab Announce Regional Strategic Collaboration And License Agreement For TIVDAK; Seagen Will Receive An Upfront Payment Of $30M, As Well As Development, Regulatory, And Commercial Milestone Payments, And Tiered Royalties On Sales Of TIVDAK

SeaGen和再鼎医药-SB宣布达成TIVDAK的区域战略合作和许可协议;Seagen将获得3000万美元的预付款,以及开发、监管和商业里程碑付款,以及销售TIVDAK的分级特许权使用费

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发